Cargando…

Qualitative Findings on the Impact of Disease in Epstein–Barr Virus-Driven Post-Transplant Lymphoproliferative Disease Patients, as Measured by EQ-5D, SF-36, and the FACT-LYM

INTRODUCTION: There are no validated patient-reported outcome (PRO) instruments for Epstein–Barr virus-driven post-transplant lymphoproliferative disease (EBV(+) PTLD). The aim of this study was to assess the content applicability for three frequently used PRO instruments from the perspective of pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watson, Crystal, Barlev, Arie, Cole, Jason C., Trivedi, Bhumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683689/ https://www.ncbi.nlm.nih.gov/pubmed/33052502 http://dx.doi.org/10.1007/s40487-020-00131-3

Ejemplares similares

Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases
por: Wongwiwat, Wiyada, et al.
Publicado: (2022)

Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases
por: Kim, Wook Youn, et al.
Publicado: (2019)

Editorial: Epstein-Barr Virus-Associated T/NK-Cell Lymphoproliferative Diseases
por: Fujiwara, Shigeyoshi, et al.
Publicado: (2019)

Epstein-Barr virus induced hemophagocytic lymphohistiocytosis in X-linked lymphoproliferative disease
por: Sankararaman, Senthilkumar, et al.
Publicado: (2014)

Epstein Barr virus-associated lymphoproliferative diseases: the virus as a therapeutic target
por: Tse, Eric, et al.
Publicado: (2015)

Inherited Immunodeficiencies With High Predisposition to Epstein–Barr Virus-Driven Lymphoproliferative Diseases
por: Latour, Sylvain, et al.
Publicado: (2018)

Epstein-Barr Virus-Positive T/NK-Cell Lymphoproliferative Diseases in Chinese Mainland
por: Ai, Junhong, et al.
Publicado: (2018)

Exploring the burden of short-term CHOP chemotherapy adverse events in post-transplant lymphoproliferative disease: a comprehensive literature review in lymphoma patients
por: Watson, Crystal, et al.
Publicado: (2020)

X‐linked lymphoproliferative syndrome associated with Epstein–Barr virus encephalitis and lymphoproliferative disorder
por: Mukai, Takeo, et al.
Publicado: (2023)

Induction and progression of human lymphoproliferative lesions by Epstein-Barr virus.
por: Chappuis, B B, et al.
Publicado: (1990)

Epstein–Barr virus-positive T/NK-cell lymphoproliferative disorders
por: Cai, Qingqing, et al.
Publicado: (2015)

Cytologic Analysis of Epstein-Barr Virus-Associated T/Natural Killer-Cell Lymphoproliferative Diseases
por: Yachie, Akihiro
Publicado: (2018)

The Spectrum of Epstein-Barr Virus-Associated Lymphoproliferative Disease in Korea: Incidence of Disease Entities by Age Groups
por: Cho, Eun-Yoon, et al.
Publicado: (2008)

Post-Transplant Lymphoproliferative Diseases in Pediatric Kidney Allograft Recipients with Epstein-Barr Virus Viremia
por: Hyun, Hyesun, et al.
Publicado: (2019)

Clinicopathological findings of systemic Epstein-Barr virus-positive T-lymphoproliferative diseases in younger and older adults
por: Wang, Ziyao, et al.
Publicado: (2021)

Association of Epstein-Barr virus with an angioimmunoblastic lymphadenopathy-like lymphoproliferative syndrome.
por: White, A. C., et al.
Publicado: (1989)

Transcriptomic Abnormalities in Epstein Barr Virus Associated T/NK Lymphoproliferative Disorders
por: de Mel, Sanjay, et al.
Publicado: (2019)

Case of primary intraocular lymphoproliferative disorder caused by Epstein–Barr Virus
por: Ban, Yumiko, et al.
Publicado: (2020)

Contribution of the Epstein-Barr virus to the oncogenesis of mature T-cell lymphoproliferative neoplasms
por: Barros, Mario Henrique M., et al.
Publicado: (2023)

CD30-Positive T-Cell Lymphoproliferative Disease of the Oral Mucosa in Children: A Manifestation of Epstein-Barr Virus-Associated T-Lymphoproliferative Disorder
por: Hong, Mineui, et al.
Publicado: (2015)

Expert Consensus on the Characteristics of Patients with Epstein–Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV(+) PTLD) for Whom Standard-Dose Chemotherapy May be Inappropriate: A Modified Delphi Study
por: Chaganti, Sridhar, et al.
Publicado: (2023)

Mapping SF-36 onto the EQ-5D index: how reliable is the relationship?
por: Rowen, Donna, et al.
Publicado: (2009)

Persistent Epstein-Barr viral load in Epstein-Barr viral naïve pediatric heart transplant recipients: Risk of late-onset post-transplant lymphoproliferative disease
por: Das, Bibhuti, et al.
Publicado: (2016)

Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)-induced lymphoproliferative disease and lytic viral replication
por: Bilger, Andrea, et al.
Publicado: (2017)

Erratum: Post-Transplant Lymphoproliferative Diseases in Pediatric Kidney Allograft Recipients with Epstein-Barr Virus Viremia
por: Hyun, Hyesun, et al.
Publicado: (2020)

Epstein–Barr Virus-Associated T- and NK-Cell Lymphoproliferative Diseases: A Review of Clinical and Pathological Features
por: Syrykh, Charlotte, et al.
Publicado: (2021)

Hydroa vacciniforme-like lymphoproliferative disorder (HV-LPD) is an Epstein-Barr virus (EBV) associated disease()()
por: Ordoñez-Parra, Juliana, et al.
Publicado: (2021)

Epstein Barr Virus Associated B-Cell Lymphomas and Iatrogenic Lymphoproliferative Disorders
por: Crombie, Jennifer L., et al.
Publicado: (2019)

Epstein-Barr Virus Positive B-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract
por: Ishikawa, Eri, et al.
Publicado: (2021)

Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus
por: Navari, Mohsen, et al.
Publicado: (2014)

Mapping the FACT-G cancer-specific quality of life instrument to the EQ-5D and SF-6D
por: Teckle, Paulos, et al.
Publicado: (2013)

Chronic Epstein-Barr virus infection causing both benign and malignant lymphoproliferative disorders
por: Kwun, Yoojin, et al.
Publicado: (2014)

Epstein-Barr Virus–Associated Lymphoproliferative Disorders: Review and Update on 2016 WHO Classification
por: Kim, Hyun-Jung, et al.
Publicado: (2017)

Epstein-Barr virus-associated post-transplant lymphoproliferative disorders: beyond chemotherapy treatment
por: Shahid, Sanam, et al.
Publicado: (2021)

The Epstein-Barr Virus Hacks Immune Checkpoints: Evidence and Consequences for Lymphoproliferative Disorders and Cancers
por: Biggi, Alison Felipe Bordini, et al.
Publicado: (2022)

Presence of LYM2 dependent but CERK1 independent disease resistance in Arabidopsis
por: Narusaka, Yoshihiro, et al.
Publicado: (2013)

Epstein-Barr Virus-Negative Post-Transplant Lymphoproliferative Diseases: Three Distinct Cases from a Single Center
por: Bakanay, Şule Mine, et al.
Publicado: (2014)

Hematopoietic Stem Cell Transplantation for the Treatment of Epstein-Barr Virus-Associated T- or NK-Cell Lymphoproliferative Diseases and Associated Disorders
por: Sawada, Akihisa, et al.
Publicado: (2018)

A new therapy in Epstein-Barr virus-associated lymphoproliferative disease: a case report and a revision of the literature
por: Xu, Lingling, et al.
Publicado: (2019)

Simiao Qingwen Baidu decoction inhibits Epstein–Barr virus-induced B lymphoproliferative disease and lytic viral replication
por: Yang, Xianhui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_94do1m11gs2ges3shd6od1iqrk